Rocket Lab's CEO recently sold over $110 million worth of shares, yet the stock continues to show promise with a 46% increase in the first half of 2026.
The company's Q1 2026 revenue reached $200 million, marking a 63% year-over-year growth and exceeding analyst expectations of $189.65 million. This follows a solid Q4 2025, where revenue grew by 36% to $180 million.
Rocket Lab's backlog has surged to $2.2 billion, a significant 106% increase compared to the previous year, with 70 contracted missions currently on its launch schedule. In fact, management indicated that the company sold more launches in Q1 2026 than in all of 2025 combined.
In terms of institutional interest, 71.78% of Rocket Lab’s stock is held by institutional investors, and several hedge funds have increased their positions. Notably, AQR Capital Management raised its stake by 114% in the first quarter.
Analysts are bullish on Rocket Lab, with 81% rating the stock as a buy or strong buy. The price targets vary from $111 to as high as $150, reflecting confidence in the company’s growth trajectory.
Despite the insider selling, including the CEO's sale of 1,298,622 shares at an average price of $84.92 on July 7, the company's performance remains strong.
This material is informational only and should not be considered financial advice.
